PLAINSBORO, N.J.--(BUSINESS WIRE)--OncLive® is pleased to announce that 21st Century Oncology has joined its Strategic Alliance Partnership program.
By participating in the Strategic Alliance Partnership program, 21st Century Oncology will be able to leverage OncLive’s extensive portfolio of print and online channels to raise awareness of the organization’s commitment to cutting-edge research, the ongoing clinical studies conducted by its physicians, and its leading role in applying cutting-edge therapies and technologies to integrated cancer care.
In addition to being one of the premier providers of cancer care services across multiple modalities, 21st Century Oncology is also the largest radiation oncology provider and one of the largest groups of urologists in the U.S. For more than 30 years, this physician-led company has been providing state-of-the-art, academic quality radiation therapy and other cancer treatments in a patient-centric setting focused on continuous innovation.
21st Century Oncology’s clinicians and scientists come from the most prestigious and recognized medical training centers and universities in the world, and are recognized leaders in providing collaborative cancer care that is designed to deliver better outcomes and improve patients’ quality of life.
“21st Century Oncology’s intense focus on providing comprehensive, multi-disciplinary cancer care that integrates the latest technologies, medicines, and approaches makes it an ideal match for OncLive and its mission to provide top-quality news and information to oncology clinicians and researchers,” said Jack Lepping, president of the oncology division of Intellisphere, the publisher of OncLive. “Together, our two organizations can help oncologists across the country deliver better, more patient-centered care.”
“This partnership provides an additional opportunity for 21st Century Oncology to share the latest, state-of-the-art information about research advances, clinical studies and technologies with the oncology community,” said Steven E. Finkelstein, M.D., Board Certified Radiation Oncologist and National Director of the Translational Research Consortium, the research arm of 21st Century Oncology. “We are confident that the information we learn from clinical trials and research we conduct today will improve outcomes for patients with cancer moving forward.”
This year, more than 20 cancer centers and nursing schools have joined OncLive’s Strategic Alliance Partnership program.
To learn more about OncLive®, visit www.OncLive.com.
To learn more about 21st Century Oncology, visit www.21stCenturyOncology.com.
OncLive.com is the official website for Intellisphere’s Oncology Specialty Group, which publishes Oncology & Biotech News, OncologyLive, Oncology Nursing News, and Contemporary Oncology. The mission of OncLive® and its family of publications is to provide oncology professionals with the resources and information they need in order to provide the best care for their patients. The Oncology Specialty Group is a division of Intellisphere, LLC, a leading provider of health care publishing, research, and education. To learn more, please visit www.OncLive.com.
About 21st Century Oncology
21st Century Oncology is the largest global, physician led provider of Integrated Cancer Care Services. The Company offers a comprehensive range of cancer treatment services, focused on delivering academic quality, cost-effective patient care in personal and convenient settings. Including the Oncure Transaction, the Company operates 166 treatment centers, including 133 centers located in 16 U.S. states. The Company also operates 33 centers located in six countries in Latin America. The Company holds market leading positions in most of its domestic local markets and abroad.